Virginia Catalyst Awards $500,000 to Help Enhance the Recovery from Opioid Overdoses
The Virginia Biosciences Health Research Corporation, known as Virginia Catalyst, today announced that it has awarded a $500,000 grant to a collaborative bioscience commercialization project including a team from Virginia Commonwealth University, Virginia Tech, Inova Health System and Indivior Inc., a global specialty pharmaceutical company with a 20-year legacy of leadership in patient advocacy and health policy. This grant, which includes matching funding of $500,000 provided by Indivior, is intended to catalyze the development and commercialization of life science projects that address major unmet needs for improving human health, while also contributing to Virginia’s economic growth. This project is focused on addressing neuroscience initiatives involving the treatment and care of patients recovering from an opioid overdose.
Read the full press release.
Your comment will be posted after it is approved.
Leave a Reply.